Molecular diagnostics are advancing rapidly, and in situ hybridization is benefiting from growing demand for precise, spatially resolved genetic information. Demand for ISH technologies is rising across oncology, pathology, and research. Understanding the forces behind this growth helps manufacturers, laboratories, and investors plan effectively.
A primary driver of the in situ hybridization...
